Cite
HARVARD Citation
Danlos, F. et al. (2018). Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease. European journal of cancer. pp. 21-29. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Danlos, F. et al. (2018). Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease. European journal of cancer. pp. 21-29. [Online].